By Manufacturer Type

Established Device Manufacturer (510(k)/PMA-Cleared) Market Analysis

Cross-industry research covering Established Device Manufacturer (510(k)/PMA-Cleared) across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports
1 Industries

Reports Covering Established Device Manufacturer (510(k)/PMA-Cleared)

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

Stryker, Integra LifeSciences, and DePuy Synthes (J&J) dominate orbital implant manufacturing with FDA-cleared Class II and Class III devices; ICH Q7-equivalent GMP standards for surgical implants, combined with 510(k) predicate chains, create meaningful entry barriers for new manufacturers attempting to compete on price alone.

20%

Market Share

5.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments